After delays, Johnson & Johnson has announced its Ottava robot-assisted surgical platform, which it claimed will be more flexible than other systems currently on the market.
Johnson & Johnson Developing Robot-Assisted Knee Surgery
Johnson & Johnson (NYSE:JNJ) recently said its medical device business paid an undisclosed amount to acquire French robot-assisted surgery company Orthotaxy. Founded in 2009, Orthotaxy’s proprietary technology is currently in early-stage development for total and partial knee replacements. J&J plans to expand Orthotaxy’s technology into other orthopedic surgeries as part of its bid to create a new…
Analyst: Uptake for robotic knee procedures will depend more on marketing than evidence
The adoption of robot-assisted total knee replacements will depend more on marketing that data or outcomes, Leerink Partners analysts wrote yesterday, as the leading contenders prepare to unveil their robotic total knee systems at an upcoming orthopedics conference. Based on a conference call with a pair of orthopedic surgeons who each perform roughly 200 knee…
Verb Surgical debuts robot-assisted surgery prototype
Verb Surgical, Johnson & Johnson‘s (NYSE:JNJ) joint venture with Google parent Alphabet‘s (NSDQ:GOOGL) Verily Life Sciences, said today that it debuted its 1st digital surgery prototype to its collaboration partners at Ethicon Endo-Surgery and J&J. Robotic surgery, a fast growing field dominated by Intuitive Surgical (NSDQ:ISRG) and its da Vinci system, isn’t using robots yet, according to Verily CEO Andrew Conrad. In…